Edition:
United States

Globus Medical Inc (GMED.N)

GMED.N on New York Stock Exchange

33.41USD
26 Jun 2017
Change (% chg)

$-0.54 (-1.59%)
Prev Close
$33.95
Open
$34.01
Day's High
$34.03
Day's Low
$33.33
Volume
97,843
Avg. Vol
177,326
52-wk High
$34.03
52-wk Low
$19.40

GMED.N

Chart for GMED.N

About

Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders. It is focused on products to treat patients with spine disorders. The Company's products fall under categories, which include Innovative Fusion and Disruptive Technologies. The Innovative... (more)

Overall

Beta: 0.64
Market Cap(Mil.): $3,262.11
Shares Outstanding(Mil.): 96.09
Dividend: --
Yield (%): --

Financials

  GMED.N Industry Sector
P/E (TTM): 31.11 34.18 19.01
EPS (TTM): 1.09 -- --
ROI: 12.71 13.01 -5.03
ROE: 12.99 15.52 -4.28

BRIEF-Globus Medical says received letter from FDA regarding 510(K) submission for Excelsiusgps

* Globus Medical - received letter from FDA informing co had not sufficiently addressed questions regarding 510(K) submission for Excelsiusgps

May 17 2017

BRIEF-Globus Medical reports Q1 earnings per share of $0.30

* Q1 earnings per share view $0.31 -- Thomson Reuters I/B/E/S

May 03 2017

BRIEF-Globus Medical files for non-timely 10-K

* Globus Medical - Anticipates filing its form 10-K for the fiscal year ended December 31, 2016 within the extension period Source text: [http://bit.ly/2mK6X85] Further company coverage:

Mar 01 2017

BRIEF-Globus Medical Q4 non-gaap EPS $0.31

* Globus medical reports full year and fourth quarter 2016 results

Feb 27 2017

More From Around the Web

Earnings vs. Estimates